ctrl K

Price Alert

Forte Biosciences Inc. (FBRX)

NASDAQ: FBRX · Real-Time Price · USD

11.26

0.30 (2.74%)

At close: Sep 05, 2025, 3:59 PM

11.26

0.00%

After-hours: Sep 05, 2025, 04:10 PM EDT

Forte Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	22.24M	11.96M	41.1M	42.04M
Short-Term Investments	36.12M	25.16M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	138K	544K	486K	786K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	336K	165K	70K	89K
Total Current Assets	61.35M	38.33M	41.51M	42.52M
Property-Plant & Equipment	77K	109K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	215K	653K	486K	786K
Total Assets	61.56M	38.98M	42M	43.31M
Account Payables	4.88M	1.42M	1.15M	946K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	1.55M	947K	0.00	n/a
Total Current Liabilities	9.08M	3.67M	3.18M	1.76M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	1.15M	n/a
Total Liabilities	9.08M	3.67M	3.18M	1.76M
Total Debt	n/a	n/a	n/a	n/a
Common Stock	6K	36K	21K	15K
Retained Earnings	-154M	-118.52M	-87.04M	-73.17M
Comprehensive Income	11K	4K	n/a	-43.31M
Shareholders Equity	52.48M	35.31M	38.82M	41.55M
Total Investments	36.12M	25.16M	n/a	n/a